- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Mangoceuticals acquires a global patent portfolio | 1 | Seeking Alpha | ||
| Do | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| Di | Mangoceuticals files to sell 30M shares of common stock for holders | 1 | Seeking Alpha | ||
| Di | MANGOCEUTICALS, INC. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 12.04. | Mangoceuticals signs deal for initial development of erectile dysfunction products in Mexico | 1 | Seeking Alpha | ||
| 12.04. | Mangoceuticals, Inc.: Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products | 74 | GlobeNewswire (Europe) | Signifies the first major step towards the application process for the certification of its Mango ED oral dissolvable products by Mexico's health governing agency, COFEPRIS Dallas, Texas, April 12... ► Artikel lesen | |
| 11.04. | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 26.03. | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.03. | Mangoceuticals, Inc.: MangoRx Officially Launches 'PRIME' by MangoRx, Powered by Kyzatrex®? FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment | 2 | GlobeNewswire (USA) | ||
| 08.02. | MoneyLine Sports, Inc.: Moneyline Sports Announces Kansas City and San Francisco Big Game Day Campaign With Mobile Sports App "Juice Reel" For Promotional Giveaway of MangoRx's Men's Health and Wellness Products | 228 | ACCESSWIRE | NEW YORK, NY / ACCESSWIRE / February 8, 2024 / Moneyline Sports Inc., a provider of predictive sports analytics and data products for US sports, today announced its Big Game Day and Football Finale... ► Artikel lesen | |
| 06.02. | Mangoceuticals, Inc.: MANGORX TO OFFER THE BIG GAME'S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE… SPIRITS | - | GlobeNewswire (USA) | ||
| 25.01. | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 19.01. | Mangoceuticals, Inc.: MangoRx's Brand and Products to be Featured by Barstool Sports in Week of Programming Around the Biggest Sports Event of the Year on February 11 | 1 | GlobeNewswire (USA) | ||
| 19.12.23 | MANGOCEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.12.23 | Mangoceuticals announces pricing of $1,200,000 public offering | 1 | Seeking Alpha | ||
| 15.12.23 | Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public Offering | 1 | GlobeNewswire (USA) | ||
| 15.12.23 | Why Is Mangoceuticals (MGRX) Stock Down 33% Today? | 1 | InvestorPlace | ||
| 13.12.23 | Mangoceuticals, Inc.: MANGOCEUTICALS TO INTRODUCE "PRIME", POWERED BY KYZATREX®? (CIII TESTOSTERONE UNDECANOATE CAPSULES), FOR AN FDA APPROVED ORAL TESTOSTERONE REPLACEMENT THERAPY (TRT) PRODUCT | 1 | GlobeNewswire (USA) | ||
| 12.12.23 | MANGOCEUTICALS, INC. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
| 12.12.23 | Mangoceuticals files to sell 5M shares of common stock | 1 | Seeking Alpha |
Seite:
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ORPEA | 12,614 | +5,38 % | EMEIS PURSUES ITS REFOUNDATION: 2023 Consolidated Financial Results of ORPEA S.A. | Significant improvement in non-financial indicators, with major advances for employees, residents and patients
Health and safety: decline in the work-related accident frequency rate, at 24.8... ► Artikel lesen | |
| NANO-X IMAGING | 8,920 | 0,00 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
| BUTTERFLY NETWORK | 0,706 | 0,00 % | ThinkSono Ltd: ThinkSono Releases Real-Time DVT AI Training Solution for Butterfly Network's Handheld Ultrasound Devices | LONDON, ENGLAND / ACCESSWIRE / April 23, 2024 / ThinkSono, a pioneering provider of AI-driven medical imaging solutions, is proud to announce the release of ThinkSono AI Training, a deep vein thrombosis... ► Artikel lesen | |
| GOODRX | 7,080 | 0,00 % | GoodRx Reports Fourth Quarter and Full Year 2023 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., has released its financial... ► Artikel lesen | |
| JOINT CORP | 12,080 | 0,00 % | The Joint Corp. Reports Fourth Quarter and Year-end 2023 Financial Results | - Grew 2023 Revenue 16%, System-wide Sales 12%, and System-wide Comp Sales 4% vs. 2022 - - Increased Clinic Count to 935 at Year-end 2023, Initiating Refranchising Program - SCOTTSDALE, Ariz., March... ► Artikel lesen | |
| CARMAT | 3,150 | -3,08 % | CARMAT Announces Its 2023 Annual Results and Provides an Update on Its Progress and Prospects for 2024 | 2023 sales of €2.8 million, i.e. 17 Aeson® implants, including 11 in the last quarter
2024 sales forecast of around €14 million
Active exploration of financing options to extend... ► Artikel lesen | |
| HYPERFINE | 0,831 | 0,00 % | Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | GUILFORD, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
| PROGYNY | 32,500 | 0,00 % | Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report | ||
| MIMEDX | 6,245 | 0,00 % | Mimedx Group, Cyclacel Pharmaceuticals, Predictive Oncology among healthcare movers | ||
| BIOMERICA | 0,680 | 0,00 % | Biomerica, Inc.: Biomerica Reports Third Quarter 2024 Financial Results | Fiscal Discipline Leads to Improvement as Loss per Share Narrows to $0.27 from $0.40 Amidst Sales Force Expansion for the Nine Months in Fiscal 2024 InFoods IBS Positive Clinical Data to be Presented... ► Artikel lesen | |
| ATRION | 370,00 | -6,09 % | Dividendenbekanntmachungen (14.03.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN PLC GB00BF8Q6K64 0,073 GBP 0,0853 EUR ABRDN PLC ADR US00108N1000 0,3203 USD 0,2925 EUR ACCO BRANDS CORPORATION US00081T1088 0... ► Artikel lesen | |
| ATRICURE | 22,610 | 0,00 % | AtriCure upgraded at Oppenheimer on valuation | ||
| AMWELL | 0,541 | 0,00 % | Amwell Receives Continued Listing Standard Notice From NYSE | Boston, April 04, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of healthcare software as a service, today announced that it received a notice on April 2, 2024 from the New York... ► Artikel lesen | |
| TALKSPACE | 3,080 | 0,00 % | Talkspace Announces Third Quarter 2023 Results | B2B payor revenue grew 132% year-over-year 3Q 2023 Operating expenses of $24.0 million, down 30% year-over-year Reduced Net Loss to $4.4 million and Adjusted EBITDA1 loss to $2.8 million, an improvement... ► Artikel lesen | |
| OUTSET MEDICAL | 2,380 | 0,00 % | FDA labels Outset Medical recall of Tablo hemodialysis system as Class I |
Das Unternehmen MANGOCEUTICALS INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,280 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
